Evaluation of Lipoedema Tissue Transcriptome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2024-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Lipoedema is a chronic painful disease with a fat distribution disorder affecting women. It is probably aggravated by hormonal changes. It is also discussed that a genetical predisposition might be a risk factor for developing lipoedema. The mechanisms leading to lipoedema are mostly unknown. The aim of this study is to identify molecular mechanisms and changes of the RNA-Expression pattern causing lipoedema by comparing the transcriptome of subcutaneous tissue of lipoedema patients vs. healthy subcutaneous tissue.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Building Lipedema Research Resources

NCT06180850

Lipedema

ACTIVE_NOT_RECRUITING

Effect of Ketosis on Pain and Quality of Life in Patients With Lipedema

NCT04632810

Lipedema

ACTIVE_NOT_RECRUITING NA

The National Lipedema Study

NCT05284266

Lipedema

ACTIVE_NOT_RECRUITING NA

Effect of an Low Carbon High Fat Diet on Pain- and Quality of Life in Patients With Lipedema

NCT03710798

Lipedema Obesity, Morbid

COMPLETED NA

Effect of Weight Loss on Body Composition and Metabolic Function in Women With Lipedema

NCT03271034

Lipedema Metabolism

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Lipoedema is a fat distribution disorder affecting mostly women. This chronic disease is characterized by painful fatty tissue accumulating especially at the limbs. The aetiopathogenesis of this disease is unsure. It is observed that a familial predisposition might increase the risk of developing lipoedema. Hormonal variations during puberty, pregnancy or climacteric period are also discussed as main factor for lipoedema. Molecular and genetical changes are rarely identified. The aim of this study is to identify changes in the expression pattern of fat cells causing lipoedema. One possibility to medicate this disease is to reduce the subcutaneous fatty tissue by liposuction. While this surgical procedure, a tumescent solution for reducing bleeding and pain is used. This study is also trying to identify the effect of tumescent solution to fatty tissue.

This trial is an explorative study using excised tissue by surgery to compare the gene expression pattern of subcutaneous tissue of lipoedema patients to healthy subcutaneous tissue. Therefore, lipoedema patients of mild stage, moderate stage and severe stage as well as healthy patients with lipohypertrophy as control group are included to the study. The participation was on a voluntary basis. Only patients who reached the age of majority and who are able to consent were included.

The study group patients are characterized by the typical, symmetrical and painful fat distribution especially at the limbs. The aim of the surgical treatment via liposuction of lipoedema patients is to reduce the fatty tissue, which is causing the development of oedema, the persistent pain and the formation of haematoma. The control group patients are determined by having a healthy subcutaneous fatty tissue, which was surgical reduced caused by cosmetical effects. The subcutaneous tissue therefore was reduced via liposuction following the standardised operation procedures. Starting the procedure, a small native tissue sample is collected without any additional invasive procedure. After installing a tumescent anaesthetic solution containing epinephrine and local anaesthetics subcutaneous the liposuction will be performed. The liposuction is done in power assisted liposuction technique. An additional sample of liposuctioned fat tissue treated with tumescent solution will be collected. The RNA-Expression pattern of the fatty tissue will be analysed by performing a NGS-Analysis. Changes of the RNA-Expression of lipoedema of different stages compared to normal fatty tissue will be detected. Further the effect of the intra-surgical used tumescent solution on fat cells can be detected by comparing native and treated tissue samples.

Another aim of the study is to collect data concerning anamnestic aspects, symptoms and factors possibly leading to the development and progress of the disease. These data will be analysed to identify risk factors for lipoedema.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lipedema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lipohypertrophy

Active Comparator Tissue from healthy patients with lipohypertrophy,

fat tissue

Intervention Type OTHER

fat tissue sample collected while cosmetical liposuction

Lipoedema mild stage

Experimental Tissue from lipoedema patients with mild stage (stage 1)

lipoedema tissue (stage 1)

Intervention Type OTHER

lipoedema tissue sample (stage 1) collected while medical liposuction

Lipoedema moderate stage

Experimental Tissue from lipoedema patients with moderate stage (stage 2)

lipoedema tissue (stage 2)

Intervention Type OTHER

lipoedema tissue sample (stage 2) collected while medical liposuction

Lipoedema severe stage

Experimental Tissue from lipoedema patients with severe stage (stage 3)

lipoedema tissue (stage 3)

Intervention Type OTHER

lipoedema tissue sample (stage 3) collected while medical liposuction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

fat tissue

fat tissue sample collected while cosmetical liposuction

Intervention Type OTHER

lipoedema tissue (stage 1)

lipoedema tissue sample (stage 1) collected while medical liposuction

Intervention Type OTHER

lipoedema tissue (stage 2)

lipoedema tissue sample (stage 2) collected while medical liposuction

Intervention Type OTHER

lipoedema tissue (stage 3)

lipoedema tissue sample (stage 3) collected while medical liposuction

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Lipohypertrophy: tissue from healthy patients (n=20): Consent-capable female patients ≥18 years of age with lipohypertrophy
2. Lipoedema milde stage: tissue from Lipoedema patients with mild stage 1 (n=20): Consent-capable female patients ≥18 years of age with Lipoedema (Stage 1)
3. Lipoedema moderate stage: tissue from Lipoedema patients with moderate stage 2 (n=20): Consent-capable female patients ≥18 years of age with Lipoedema (Stage 2)
4. Lipoedema severe stage: tissue from Lipoedema patients with severe stage 3 (n=20): Consent-capable female patients ≥18 years of age with Lipoedema (Stage 3)